Gengos Andrew

CIK 0001563623

See BelowDirector

Filings

Latest May 5, 2026

Issuers covered

Showing

14 of 14

Page 1

Track record

5 of 18 open-market trades scored (28% price coverage) - 13 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	5	100%	+41.1%	+31.7%	+55.4%	+31.4%
90 days	5	100%	+90.0%	+91.8%	+94.3%	+77.8%
180 days	5	100%	+1022.0%	+1006.5%	+1049.7%	+997.5%
365 days	-	-	-	-	-	-

Issuers

Companies where Gengos Andrew has filed

Ticker	Issuer	Filings	Last filed
ATHA	Athira Pharma, Inc.	7	Sep 5, 2024
TERN	Terns Pharmaceuticals, Inc.	5	May 5, 2026
CYT	Cyteir Therapeutics, Inc.	1	Feb 24, 2022
TTRX	Turn Therapeutics Inc.	1	Oct 10, 2025

All filings

14 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 5, 2026	TERNTerns Pharmaceuticals, Inc.	DDisposition	68,750	$53.00	$3,643,750
Jan 16, 2026	TERNTerns Pharmaceuticals, Inc.	AGrant	68,750	$0.00	$0
Oct 10, 2025	TTRXTurn Therapeutics Inc.	AGrant	10,000	$0.00	$0
Jun 30, 2025	TERNTerns Pharmaceuticals, Inc.	PPurchase	5,000	$3.9299	$19,650
Jun 16, 2025	TERNTerns Pharmaceuticals, Inc.	PPurchase	5,000	$3.9465	$19,733
Feb 25, 2025	TERNTerns Pharmaceuticals, Inc.	Holdings only	-	-	-
Sep 5, 2024	ATHAAthira Pharma, Inc.	AGrant	10,000	$1.34	$13,400
Feb 16, 2024	ATHAAthira Pharma, Inc.A	SSale	1,208	$2.91	$3,515
Feb 16, 2024	ATHAAthira Pharma, Inc.	Holdings only	-	-	-
Jan 8, 2024	ATHAAthira Pharma, Inc.	SSale	1,208	$2.91	$3,515
Jun 9, 2023	ATHAAthira Pharma, Inc.	PPurchase	11,719	$3.4395	$40,308
Jun 6, 2023	ATHAAthira Pharma, Inc.	PPurchase	15,000	$3.00	$45,000
May 22, 2023	ATHAAthira Pharma, Inc.	Holdings only	-	-	-
Feb 24, 2022	CYTCyteir Therapeutics, Inc.	Holdings only	-	-	-

Showing 1-14 of 14

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value